Trials / Conditions / Facio-Scapulo-Humeral Dystrophy

Facio-Scapulo-Humeral Dystrophy

12 registered clinical trials studyying Facio-Scapulo-Humeral Dystrophy — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Followi NCT07072676	LMU Klinikum	N/A
Recruiting	A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD NCT07038200	Avidity Biosciences, Inc.	Phase 3
Enrolling By Invitation	Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FS NCT06547216	Avidity Biosciences, Inc.	Phase 2
Recruiting	Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844	Centre Hospitalier Universitaire de Liege	N/A
Recruiting	Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1 NCT06131983	Arrowhead Pharmaceuticals	Phase 1 / Phase 2
Recruiting	Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI] NCT06378203	IRCCS Eugenio Medea	N/A
Active Not Recruiting	Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) NCT05747924	Avidity Biosciences, Inc.	Phase 1 / Phase 2
Completed	Understanding Control and Mechanisms of Shoulder Instability in FSHD NCT05239520	University of Liverpool	—
Completed	Examination of Operative Approach in pwFSHD (Patient With Facioscapulohumeral Muscular Dystrophy) NCT05022355	Istanbul University - Cerrahpasa	—
Terminated	FSHD Molecular Characterization NCT06096441	Nationwide Children's Hospital	—
Completed	Computerized Facial Recognition for Automated Diagnosis of the Facio-Scapulo-Humeral Muscular Dystrophy (FSMHD NCT04377217	Centre Hospitalier Universitaire de Nice	N/A
Completed	Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD NCT02948244	Murdoch Childrens Research Institute	N/A